A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma

Martin Dreyling, Constantine S. Tam, Michael Wang, Stephen D. Smith, Marco Ladetto, Hui-Qiang Huang, William Novotny, Melannie Co, Alfredo Romano, Eric Holmgren, Jane Huang, Steven Le Gouill

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Phase III study of zanubrutinib plus rituximab versus bendamustine plus rituximab in transplant-ineligible, untreated mantle cell lymphoma'. Together they form a unique fingerprint.

Medicine & Life Sciences